FDA Label for Deferasirox
View Indications, Usage & Precautions
Deferasirox Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 70771-1409-3
Deferasirox Tablets for Oral Suspension, 125 mg
30 Tablets
Rx only
NDC 70771-1410-3
Deferasirox Tablets for Oral Suspension, 250 mg
30 Tablets
Rx only
NDC 70771-1411-3
Deferasirox Tablets for Oral Suspension, 500 mg
30 Tablets
Rx only
* Please review the disclaimer below.